CAS 10161-87-2

4-(4-(2-Bromoacetamido)butyl)benzoic acid

CAS: 10161-87-2

4-(4-(2-Bromoacetamido)butyl)benzoic acid

Formel: C₁₃H₁₆BrNO₃

Reinheit: 98%

Molekulargewicht: 314.18

Ref: 54-OR1067734

KRA-533

CAS: 10161-87-2

4-(4-(2-Bromoacetamido)butyl)benzoic acid

Formel: C₁₃H₁₆BrNO₃

Reinheit: 98%

Molekulargewicht: 314.18

Ref: IN-DG01438738

Benzoic acid, 4-[4-[(2-bromoacetyl)amino]butyl]-

CAS: 10161-87-2

Formel: C₁₃H₁₆BrNO₃

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 314.1750

Ref: IN-DA0004YX

KRA-533

CAS: 10161-87-2

KRA-533 is an effective KRAS agonist that targets the GTP/GDP binding pocket within the KRAS protein, inhibiting GTP cleavage.

Formel: C₁₃H₁₆BrNO₃

Reinheit: 98.11%

Farbe und Form: Solid

Molekulargewicht: 314.18

Ref: TM-T38411

4-{4-[(Bromoacetyl)amino]butyl}benzoic acid

CAS: 10161-87-2

4-{4-[(Bromoacetyl)amino]butyl}benzoic acid is a ligand that binds to Ion channels. 4-{4-[(Bromoacetyl)amino]butyl}benzoic acid is a bidentate ligand, which interacts with the extracellular loops of the receptor. This compound has been shown to activate both potassium and chloride ion channels. 4-{4-[(Bromoacetyl)amino]butyl}benzoic acid has also been shown to inhibit the activity of beta adrenergic receptors, leading to hypotension and bradycardia in animals. 4-{4-[(Bromoacetyl)amino]butyl}benzoic acid is a high purity research tool that can be used for studying protein interactions, peptides, antibodies, cell biology and pharmacology.

Formel: C₁₃H₁₆BrNO₃

Reinheit: Min. 95%

Molekulargewicht: 314.17 g/mol

Ref: 3D-KAA16187